Immediate Impact
1 from Science/Nature 31 standout
Citing Papers
EASL-ILCA Clinical Practice Guidelines on the management of intrahepatic cholangiocarcinoma
2023 Standout
Efficacy and Safety of Trastuzumab Deruxtecan in Patients With HER2-Expressing Solid Tumors: Primary Results From the DESTINY-PanTumor02 Phase II Trial
2023 Standout
Works of É Juhos being referenced
Cetuximab, gemcitabine and capecitabine in patients with inoperable biliary tract cancer: A phase 2 study
2013
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| É Juhos | 28 | 45 | 12 | 42 | 17 | 116 | |
| Julien Fraisse | 20 | 48 | 9 | 28 | 19 | 153 | |
| Carla Renata Pacheco Donato Macedo | 44 | 21 | 17 | 44 | 15 | 115 | |
| Jennie Olofsson | 54 | 44 | 12 | 40 | 15 | 156 | |
| H Kellner | 27 | 43 | 4 | 24 | 18 | 197 | |
| Haojun Ouyang | 40 | 62 | 21 | 21 | 14 | 130 | |
| Angeline Ginzac | 45 | 74 | 24 | 24 | 21 | 188 | |
| Cristina Morelli | 50 | 117 | 36 | 49 | 23 | 186 | |
| Mriganki Chaudhary | 27 | 18 | 16 | 40 | 14 | 134 | |
| J. Peña | 23 | 23 | 7 | 21 | 20 | 126 | |
| Prerna Guleria | 27 | 49 | 10 | 51 | 24 | 137 |
All Works
Loading papers...